OCX

Oncocyte Corporation (OCX)

About Oncocyte Corporation (OCX)

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Details

Daily high
$3.20
Daily low
$2.94
Price at open
$3.18
52 Week High
$4.34
52 Week Low
$2.08
Market cap
39.9M
Dividend yield
0.00%
Volume
40,797
Avg. volume
15,128
P/E ratio
-.70

Oncocyte Corporation News

Details

Daily high
$3.20
Daily low
$2.94
Price at open
$3.18
52 Week High
$4.34
52 Week Low
$2.08
Market cap
39.9M
Dividend yield
0.00%
Volume
40,797
Avg. volume
15,128
P/E ratio
-.70